These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 3301950)

  • 1. Treatment of psoriasis vulgaris with oral 1 alpha,25-dihydroxyvitamin D3--report of two cases.
    Morimoto S; Yoshikawa K; Kozuka T; Kitano Y; Imanaka S; Fukuo K; Koh E; Hironaka T; Zen A; Nabata T
    J Dermatol; 1987 Feb; 14(1):59-62. PubMed ID: 3301950
    [No Abstract]   [Full Text] [Related]  

  • 2. Topical administration of 1,25-dihydroxyvitamin D3 for psoriasis: report of five cases.
    Morimoto S; Onishi T; Imanaka S; Yukawa H; Kozuka T; Kitano Y; Yoshikawa K; Kumahara Y
    Calcif Tissue Int; 1986 Feb; 38(2):119-22. PubMed ID: 3082494
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inverse relation between severity of psoriasis and serum 1,25-dihydroxy-vitamin D level.
    Morimoto S; Yoshikawa K; Fukuo K; Shiraishi T; Koh E; Imanaka S; Kitano S; Ogihara T
    J Dermatol Sci; 1990 Jul; 1(4):277-82. PubMed ID: 2095195
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Psoriasis and vitamin D3. A review of our experience.
    Morimoto S; Yoshikawa K
    Arch Dermatol; 1989 Feb; 125(2):231-4. PubMed ID: 2536537
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Climatotherapy at the Dead Sea stimulates vitamin D3 metabolism.
    Kragballe K; Avrach WW; Politi Y; Landau M; Brenner S
    Acta Derm Venereol; 1996 Jul; 76(4):324-5. PubMed ID: 8869697
    [No Abstract]   [Full Text] [Related]  

  • 6. An open study of vitamin D3 treatment in psoriasis vulgaris.
    Morimoto S; Yoshikawa K; Kozuka T; Kitano Y; Imanaka S; Fukuo K; Koh E; Kumahara Y
    Br J Dermatol; 1986 Oct; 115(4):421-9. PubMed ID: 3022784
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improvement of psoriasis by a topical vitamin D3 analogue (MC 903) in a double-blind study.
    Kragballe K; Beck HI; Søgaard H
    Br J Dermatol; 1988 Aug; 119(2):223-30. PubMed ID: 3048369
    [No Abstract]   [Full Text] [Related]  

  • 8. Bone turnover in rats treated with 1,25-dihydroxyvitamin D3, 25-hydroxyvitamin D3 or 24,25-dihydroxyvitamin D3.
    Mortensen BM; Gautvik KM; Gordeladze JO
    Biosci Rep; 1993 Feb; 13(1):27-39. PubMed ID: 8392394
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effects of topical calcipotriol on systemic calcium homeostasis in patients with chronic plaque psoriasis.
    Bourke JF; Mumford R; Whittaker P; Iqbal SJ; Le Van LW; Trevellyan A; Hutchinson PE
    J Am Acad Dermatol; 1997 Dec; 37(6):929-34. PubMed ID: 9418759
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Short-term effects of renal transplantation on the metabolism of vitamin D3.
    Saha H; Salmela K; Ahonen J; Pietilä K; Mörsky P; Pasternack A
    Transplant Proc; 1992 Feb; 24(1):367-8. PubMed ID: 1539320
    [No Abstract]   [Full Text] [Related]  

  • 11. Calcium status and calcium-regulating hormones in alcoholics.
    Bjørneboe GE; Bjørneboe A; Johnsen J; Skylv N; Oftebro H; Gautvik KM; Høiseth A; Mørland J; Drevon CA
    Alcohol Clin Exp Res; 1988 Apr; 12(2):229-32. PubMed ID: 2837104
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Behavior of calciotropic hormones in psoriasis.
    Rico H; Robledo A; Crabranes JA; Lopez-Bran E; Hernandez ER
    Miner Electrolyte Metab; 1991; 17(1):12-5. PubMed ID: 1770911
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term efficacy and safety of tacalcitol ointment in patients with chronic plaque psoriasis.
    van de Kerkhof PC; Berth-Jones J; Griffiths CE; Harrison PV; Hönigsmann H; Marks R; Roelandts R; Schöpf E; Trompke C
    Br J Dermatol; 2002 Mar; 146(3):414-22. PubMed ID: 11952541
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Calcitriol (1 alpha,25-dihydroxyvitamin D3) ointment in psoriasis, a safety tolerance and efficacy multicentre study.
    Wishart JM
    Dermatology; 1994; 188(2):135-9. PubMed ID: 8136540
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Calcium regulating hormones after oral and intravenous calcium administration.
    Herfarth K; Drechsler S; Imhoff W; Schlander M; Engelbach M; Maier A; Schmidt-Gayk H
    Eur J Clin Chem Clin Biochem; 1992 Dec; 30(12):815-22. PubMed ID: 1489856
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A double-blind study of topical 1 alpha,25-dihydroxyvitamin D3 in psoriasis.
    van de Kerkhof PC; van Bokhoven M; Zultak M; Czarnetzki BM
    Br J Dermatol; 1989 May; 120(5):661-4. PubMed ID: 2667612
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oral calcitriol (1,25-dihydroxyvitamin D3) does not augment UVB phototherapy for plaque psoriasis.
    Prystowsky JH; Knobler EH; Muzio PJ
    J Am Acad Dermatol; 1996 Aug; 35(2 Pt 1):272-4. PubMed ID: 8708038
    [No Abstract]   [Full Text] [Related]  

  • 18. Modified-release oral calcifediol corrects vitamin D insufficiency with minimal CYP24A1 upregulation.
    Petkovich M; Melnick J; White J; Tabash S; Strugnell S; Bishop CW
    J Steroid Biochem Mol Biol; 2015 Apr; 148():283-9. PubMed ID: 25446887
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety and efficacy of oral calcitriol (1,25-dihydroxyvitamin D3) for the treatment of psoriasis.
    Perez A; Raab R; Chen TC; Turner A; Holick MF
    Br J Dermatol; 1996 Jun; 134(6):1070-8. PubMed ID: 8763427
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum parathyroid hormone suppression by intravenous 1,25-dihydroxyvitamin D3 in patients on maintenance haemodialysis.
    Rassoul Z; Mousa D; Rehman MA; Abdalla AH; Hawas F; Popovich W; Gaisoum M; al-Sulaiman M; Al-Khader A
    Am J Nephrol; 1995; 15(6):507-11. PubMed ID: 8546173
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.